Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA; email:
Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.
Annu Rev Pathol. 2021 Jan 24;16:69-91. doi: 10.1146/annurev-pathmechdis-012419-032817. Epub 2020 Nov 23.
Merkel cell carcinoma (MCC) is an aggressive neuroendocrine carcinoma of the skin with two distinct etiologies. Clonal integration of Merkel cell polyomavirus DNA into the tumor genome with persistent expression of viral T antigens causes at least 60% of all MCC. UV damage leading to highly mutated genomes causes a nonviral form of MCC. Despite these distinct etiologies, both forms of MCC are similar in presentation, prognosis, and response to therapy. At least three oncogenic transcriptional programs feature prominently in both forms of MCC driven by the virus or by mutation. Both forms of MCC have a high proliferative growth rate with increased levels of cell cycle-dependent genes due to inactivation of the tumor suppressors RB and p53, a strong MYC signature due to MYCL activation by the virus or gene amplification, and an attenuated neuroendocrine differentiation program driven by the ATOH1 transcription factor.
默克尔细胞癌(Merkel cell carcinoma,MCC)是一种具有两种不同病因的侵袭性皮肤神经内分泌癌。Merkel 细胞多瘤病毒 DNA 的克隆整合到肿瘤基因组中,并持续表达病毒 T 抗原,导致至少 60%的 MCC。紫外线损伤导致高度突变的基因组导致非病毒形式的 MCC。尽管存在这两种不同的病因,但两种形式的 MCC 在表现、预后和对治疗的反应方面都相似。至少有三种致癌转录程序在由病毒或突变驱动的两种形式的 MCC 中显著突出。由于肿瘤抑制因子 RB 和 p53 的失活,两种形式的 MCC 均具有较高的增殖生长速度,细胞周期依赖性基因水平升高,由于病毒或基因扩增激活 MYCL,导致 MYC 特征明显,以及由 ATOH1 转录因子驱动的神经内分泌分化程序减弱。